Intellia Therapeutics Inc (NTLA)
SBC to Revenue
236.00%
Quarterly · Period ending:
NTLA SBC to Revenue
Latest reported236.00%period ending
Latest reported236.00%period ending
NTLA Quarterly SBC/Revenue (0.00% → 236.00%)
Latest values, visible window
High-resolution chart · PNG
NTLA sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 235.9969% | |
| 89.5734% | |
| 394.4606% | |
| 142.2435% | |
| 154.6929% | |
| 131.3526% | |
| 307.7288% | |
| 434.848% | |
| 587.3365% | |
| 118.113% | |
| -1,828.0125% | |
| 294.7965% | |
| 267.7652% | |
| 216.2066% | |
| 181.4337% | |
| 190.0724% | |
| 164.4191% | |
| 164.3352% | |
| 113.2799% | |
| 213.9089% | |
| 162.0458% | |
| 99.6742% | |
| 84.6399% | |
| 24.3024% | |
| 29.2935% | |
| 32.1849% | |
| 27.5786% | |
| 29.0034% | |
| 39.6114% | |
| 44.0142% | |
| 45.4569% | |
| 60.1512% | |
| 63.84% | |
| 54.9873% | |
| 98.9202% | |
| 44.3761% | |
| 48.1494% | |
| 42.317% | |
| 35.8095% | |
| 42.2058% | |
| 43.5806% | |
| 45.695% | |
| 27.3479% | |
| 34.3009% | |
| 10.9659% | |
| 8.9425% | |
| 0% | |
| 0% |